标题
Therapeutic options for carbapenem-resistant Enterobacteriaceae infections
作者
关键词
-
出版物
Virulence
Volume 8, Issue 4, Pages 470-484
出版商
Informa UK Limited
发表日期
2017-02-09
DOI
10.1080/21505594.2017.1292196
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Bloodstream infections caused byKlebsiella pneumoniaein onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey
- (2016) Enrico Maria Trecarichi et al. AMERICAN JOURNAL OF HEMATOLOGY
- Combination Regimens for Treatment of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections
- (2016) A. Gomez-Simmonds et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftazidime-avibactam as salvage therapy for infections caused by carbapenem-resistant organisms: a case series from the compassionate-use program
- (2016) Elizabeth Temkin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections: Table 1.
- (2016) Ryan K. Shields et al. CLINICAL INFECTIOUS DISEASES
- Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase–producing K. pneumoniae
- (2016) M. Falcone et al. CLINICAL MICROBIOLOGY AND INFECTION
- Bactericidal and synergistic activity of double-carbapenem regimen for infections caused by carbapenemase-producing Klebsiella pneumoniae
- (2016) A. Oliva et al. CLINICAL MICROBIOLOGY AND INFECTION
- Fosfomycin
- (2016) Matthew E. Falagas et al. CLINICAL MICROBIOLOGY REVIEWS
- The management of multidrug-resistant Enterobacteriaceae
- (2016) Matteo Bassetti et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infections
- (2016) Marco Falcone et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: Should we get to the PK/PD root of the paradox?
- (2016) Valerio Del Bono et al. Virulence
- The global epidemiology of carbapenemase-producing Enterobacteriaceae
- (2016) David van Duin et al. Virulence
- Influence of Colistin Dose on Global Cure in Patients with Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacilli
- (2015) Gabrielle A. Gibson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae
- (2015) Jessica B. Cprek et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment of KPC-producing Enterobacteriaceae: suboptimal efficacy of polymyxins
- (2015) M.S. de Oliveira et al. CLINICAL MICROBIOLOGY AND INFECTION
- Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case–control–control study
- (2015) D.R. Giacobbe et al. CLINICAL MICROBIOLOGY AND INFECTION
- Therapeutic strategy for pandrug-resistant Klebsiella pneumoniae severe infections: short-course treatment with colistin increases the in vivo and in vitro activity of double carbapenem regimen
- (2015) Alessandra Oliva et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study
- (2015) Mario Tumbarello et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control
- (2015) T. Tängdén et al. JOURNAL OF INTERNAL MEDICINE
- Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems
- (2014) George L. Daikos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treating infections caused by carbapenemase-producing Enterobacteriaceae
- (2014) L.S. Tzouvelekis et al. CLINICAL MICROBIOLOGY AND INFECTION
- Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections
- (2014) A. Oliva et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Gentamicin therapy for sepsis due to carbapenem-resistant and colistin-resistant Klebsiella pneumoniae
- (2014) M. Gonzalez-Padilla et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Successful Ertapenem-Doripenem Combination Treatment of Bacteremic Ventilator-Associated Pneumonia Due to Colistin-Resistant KPC-Producing Klebsiella pneumoniae
- (2013) Giancarlo Ceccarelli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effectiveness of a Double-Carbapenem Regimen for Infections in Humans Due to Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae
- (2013) Helen Giamarellou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synergistic Activity of Colistin plus Rifampin against Colistin-Resistant KPC-Producing Klebsiella pneumoniae
- (2013) Carlo Tascini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome and therapeutic options
- (2013) F. Kontopidou et al. CLINICAL MICROBIOLOGY AND INFECTION
- Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes
- (2013) David van Duin et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Treatment of carbapenem-resistantKlebsiella pneumoniae: the state of the art
- (2013) Nicola Petrosillo et al. Expert Review of Anti-Infective Therapy
- Predictors of mortality in multidrug-resistantKlebsiella pneumoniaebloodstream infections
- (2013) Pierluigi Viale et al. Expert Review of Anti-Infective Therapy
- Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria
- (2013) Konstantinos Pontikis et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens
- (2012) Zubair A. Qureshi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenem-Sparing Antibiotic Regimens for Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit
- (2012) F. Sbrana et al. CLINICAL INFECTIOUS DISEASES
- Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
- (2012) M. Tumbarello et al. CLINICAL INFECTIOUS DISEASES
- Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
- (2012) R. Cantón et al. CLINICAL MICROBIOLOGY AND INFECTION
- High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality
- (2012) A. Capone et al. CLINICAL MICROBIOLOGY AND INFECTION
- Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions
- (2012) L. S. Tzouvelekis et al. CLINICAL MICROBIOLOGY REVIEWS
- Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae
- (2011) Catharine C. Bulik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment
- (2011) O. Zarkotou et al. CLINICAL MICROBIOLOGY AND INFECTION
- Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?
- (2011) G.L. Daikos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation
- (2009) A. Michalopoulos et al. CLINICAL MICROBIOLOGY AND INFECTION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started